How GLP-1 Weight-Loss Drugs Like Ozempic and Wegovy Are Rewriting the Neuroscience of Addiction and Cravings
For millions of individuals worldwide, the mere thought of a savory burger, a sweet pastry, or a cold pint of…
Unlocking the Neurochemical Architecture of Schizophrenia: Groundbreaking PET Imaging Study Reveals Widespread Synaptic Loss in the Living Brain
In what is being hailed as a major milestone in neuropsychiatric research, a collaborative team of international scientists has gained…
Debunking the Top 5 Myths About Polycystic Ovary Syndrome and Weight Loss
Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age, yet it remains…
Regulatory Shift in Hair Restoration as JCCP Classifies PRP Procedures for Hair Loss as Medical Treatments
The Joint Council for Cosmetic Practitioners (JCCP) has released comprehensive new guidance regarding platelet-rich plasma (PRP) procedures, establishing a definitive…
Five Powerful Supplements for Managing PCOS Symptoms and Supporting Sustainable Weight Loss
Polycystic Ovary Syndrome (PCOS) remains one of the most prevalent endocrine disorders globally, affecting an estimated 8% to 13% of…
Omni Secures £11M Series A Funding to Fuel Expansion and Launch Innovative Dog Weight-Loss Supplement
London-based vegan pet food maker Omni has successfully closed an £11 million (approximately $14.5 million) Series A funding round, spearheaded…
New Investigational Drug Apitegromab Shows Promise in Mitigating Muscle Loss for Patients on GLP-1 Obesity Treatments
Clinical researchers and biotechnology experts are pivoting their focus toward the "quality" of weight loss as the global adoption of…
